110 related articles for article (PubMed ID: 6106785)
1. Skeletal uptake of diphosphonate. Method for prediction of post-menopausal osteoporosis.
Fogelman I; Bessent RG; Cohen HN; Hart DM; Lindsay R
Lancet; 1980 Sep; 2(8196):667-70. PubMed ID: 6106785
[TBL] [Abstract][Full Text] [Related]
2. Age-related alterations in skeletal metabolism--24-hr whole-body retention of diphosphonate in 250 normal subjects: concise communication.
Fogelman I; Bessent R
J Nucl Med; 1982 Apr; 23(4):296-300. PubMed ID: 6802938
[TBL] [Abstract][Full Text] [Related]
3. GFR-corrected 24-hour whole body retention of diphosphonate: an improved index of bone metabolism.
Hyldstrup L; McNair P; Transbøl I
Scand J Clin Lab Invest; 1988 Jun; 48(4):341-5. PubMed ID: 3238315
[TBL] [Abstract][Full Text] [Related]
4. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
[TBL] [Abstract][Full Text] [Related]
5. Measurements of whole body retention of diphosphonate and other indices of bone metabolism in 125 normals: dependency on age, sex and glomerular filtration.
Hyldstrup L; McNair P; Finn Jensen G; Borg Mogensen N; Transbøl I
Scand J Clin Lab Invest; 1984 Dec; 44(8):673-8. PubMed ID: 6528212
[TBL] [Abstract][Full Text] [Related]
6. Does radiolabelled diphosphonate retention reflect bone metabolism in the elderly?
Webb AJ; Sinha B; Briggs RS; Fleming J; Ackery D
Age Ageing; 1986 May; 15(3):164-8. PubMed ID: 3739853
[TBL] [Abstract][Full Text] [Related]
7. Increased bone metabolism in rheumatoid arthritis as measured by the whole-body retention of 99Tcm methylene diphosphonate.
Rajapakse C; Thompson R; Grennan DM; Winston BM; Patel P; Nuttall PM; Murphy J; Weiss JB
Ann Rheum Dis; 1983 Apr; 42(2):138-41. PubMed ID: 6221703
[TBL] [Abstract][Full Text] [Related]
8. [Whole-body retention of 99mTc-methylene diphosphonate in skeletal diseases].
Zorn-Bopp E; Büll U; Münzing W; Lang P; Moser EA
Nuklearmedizin; 1983 Feb; 22(1):24-30. PubMed ID: 6223277
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women.
Lindsay R; Hart DM; Purdie D; Ferguson MM; Clark AS; Kraszewski A
Clin Sci Mol Med; 1978 Feb; 54(2):193-5. PubMed ID: 340117
[TBL] [Abstract][Full Text] [Related]
10. Whole body retention of 99mTc-diphosphonate. Relation to biochemical indices of bone turnover and to total body calcium.
Thomsen K; Johansen J; Nilas L; Christiansen C
Eur J Nucl Med; 1987; 13(1):32-5. PubMed ID: 3109915
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with two simple methods of measurement of 99mTc-methylene diphosphonate body retention in bone disease.
Reschini E; Ulivieri FM; Ortolani S
J Nucl Biol Med (1991); 1991; 35(3):123-30. PubMed ID: 1816867
[TBL] [Abstract][Full Text] [Related]
12. Assessment of synthetic steroid (Org OD 14): effect on skeletal metabolism by 24-h whole-body retention of diphosphonate.
Fogelman I; Bessent RG; Smith ML; Hart DM; Lindsay R
Maturitas; 1981 Dec; 3(3-4):265-9. PubMed ID: 6801438
[TBL] [Abstract][Full Text] [Related]
13. Isotope retention for assessment of bone turnover in involutional osteoporosis.
Passeri M; Palummeri E; Baroni MC; Quaini F; Quintavalla A; Barbagallo M; Franchini D; Ugolotti D
Clin Rheumatol; 1989 Jun; 8 Suppl 2():35-40. PubMed ID: 2788063
[TBL] [Abstract][Full Text] [Related]
14. The prevention and management of post-menopausal osteoporosis.
Marshall DH; Horsman A; Nordin BE
Acta Obstet Gynecol Scand Suppl; 1977; 65():49-56. PubMed ID: 269626
[TBL] [Abstract][Full Text] [Related]
15. Serum bone Gla protein and other biochemical estimates of bone turnover in early postmenopausal women during prophylactic treatment for osteoporosis.
Pødenphant J; Christiansen C; Catherwood BD; Deftos LJ
Acta Med Scand; 1985; 218(3):329-33. PubMed ID: 3907290
[TBL] [Abstract][Full Text] [Related]
16. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
Civitelli R; Gonnelli S; Zacchei F; Bigazzi S; Vattimo A; Avioli LV; Gennari C
J Clin Invest; 1988 Oct; 82(4):1268-74. PubMed ID: 3262626
[TBL] [Abstract][Full Text] [Related]
17. Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment.
Lindsay R; Hart DM; Aitken JM; MacDonald EB; Anderson JB; Clarke AC
Lancet; 1976 May; 1(7968):1038-41. PubMed ID: 57448
[TBL] [Abstract][Full Text] [Related]
18. Urinary 99m-Tc-diphosphonate excretion as a simple method to quantify bone metabolism.
Hyldstrup L; Mogensen N; Jensen GF; McNair P; Transbøl I
Scand J Clin Lab Invest; 1984 Apr; 44(2):105-9. PubMed ID: 6426035
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonate whole body retention test: relations to bone mineralization rate, renal function and bone mineral content in osteoporosis and metabolic bone disorders.
Mosekilde L; Hasling C; Tågehøj Jensen PC; Tågehøj Jensen F
Eur J Clin Invest; 1987 Dec; 17(6):530-7. PubMed ID: 3123252
[TBL] [Abstract][Full Text] [Related]
20. The usefulness of bone turnover in predicting the response to transdermal estrogen therapy in postmenopausal osteoporosis.
Gonnelli S; Cepollaro C; Pondrelli C; Martini S; Monaco R; Gennari C
J Bone Miner Res; 1997 Apr; 12(4):624-31. PubMed ID: 9101374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
